S-63845 free base · Synonyms: S 63845 · S63845
S63845 is a potent and selective myeloid cell leukemia 1 inhibitor.
For research use only. Not for human or veterinary use.
S-63845 structure
CAS No.: 1799633-27-4
Pack sizes & pricing
Description
S63845 is a potent and selective myeloid cell leukemia 1 (MCL1) inhibitor with a Kd of 0.19 nM for human MCL1.
Biological activity
In vitro: The pro-survival protein myeloid cell leukemia 1 (MCL1) is over expressed in many cancers. S63845 is a small molecule that specifically binds with high affinity to the BH3-binding groove of MCL1. S63845 potently kills MCL1-dependent cancer cells, including multiple myeloma, leukaemia and lymphoma cells, by activating the BAX/BAK-dependent mitochondrial apoptotic pathway. The activity of S63845 is next evaluated in a panel of eight AML cell lines: all lines are sensitive to S63845 (IC50=4-233 nM). In vivo: S63845 shows potent anti-tumour activity with an acceptable safety margin as a single agent in several cancers. Intravenously injected (i.v.) S63845 exerts dose-dependent anti-tumour activity in human multiple myeloma (H929 and AMO1) xenografts in immunocompromised mice, with maximal tumour growth inhibition of 114% in the AMO1 model and 103% in the H929 model. At 25 mg/kg, S63845 induces complete regression in 7 out of 8 of the mice at 100 days after treatment in the AMO1 model.
Identifiers
- SMILES
-
CN1CCN(CCOC2=C(Cl)C(C)=C(C=C2)C2=C(SC3=NC=NC(O[C@H](CC4=C(OCC5=CC=NN5CC(F)(F)F)C=CC=C4)C(O)=O)=C23)C2=CC=C(F)O2)CC1 - InChIKey
-
ZFBHXVOCZBPADE-SSEXGKCCSA-N
Specifications
- MW (average)
- 829.2590
- Formula
- C39H37ClF4N6O6S
- CAS No.
- 1799633-27-4
- Physical state
- Solid
- Color
- White to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
- In vitro
- DMSO : 100 mg/mL
Documents
References
Same target
Search Bcl-2 FamilySame research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%